Insights

Succession of the founder and of the CEO in Spinverse

The innovation funding consultancy Spinverse takes another considerable step on its journey from founder-led family company, as the founder and Vice-Chair Pekka Koponen announces his transition from his active roles in the company to become a full-time investor at his family investment company Infinit Capital Oy. Laura Koponen, current CEO of Spinverse, will succeed Pekka as Vice-Chair and leave her role as CEO. 

Read More

IRIS Smart Cities: Creating smart and sustainable cities

IMCG, now part of Spinverse, was a key partner in the HORIZON 2020 EU funded project, IRIS (Integrated and Replicable solutions for co-creation in Sustainable cities), which received 18 million euros in funding and aimed to accelerate the adoption of smart sustainable city solutions across Europe. Over the course of the five and a half years until March 2023, the project brought together more than 50 partners and seven European cities with a mission to build a more sustainable future for our cities and the people who call them home.

Read More

Innovation Fund small-scale 2023 call has opened: Scale up your technology for more GHG emission savings

Since 2021, CINEA (European Climate, Infrastructure and Environment Executive Agency) is organizing Innovation Fund instruments, annual EUR multi-billion calls to decrease industrial carbon footprint and improve European capacity in key resource areas. This year, the small-scale Innovation Fund call is expected to finance around 100 M€ grants for disruptive technologies capable of significant greenhouse gas (GHG) savings compared to the current scenario. Is your technology ready to take off from pilot to full industrial scale?

Read More

New colleagues joining us bring loads of expertise for us and our customers

We are excited to introduce our newest team members, a group of accomplished professionals whose skills and expertise will help take Spinverse to the next level. With backgrounds in business development, innovation funding, project management, healthcare, and marketing, our new additions bring a wealth of experience and fresh perspectives to our team. We cannot wait to see what we’ll achieve together.

Read More

Spinverse helped Herantis Pharma secure EIC Accelerator funding to prepare Phase 2 in their treatment for Parkinson’s disease

Herantis Pharma Plc (“Herantis), a company developing disease-modifying therapies for Parkinson’s disease, announced the signing of a grant agreement with the European Innovation Council Accelerator. The funding will launch project ReTreatPD, which will focus on preparations towards a Phase 2 clinical study with HER-096 in conjunction with Parkinson’s disease. The project includes development of biomarkers for monitoring target engagement and treatment response to HER-096 molecule. 

Read More